E2022 + E2022 + E2022 + E2022 + E2022
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Japanese Healthy Male Adult Volunteers
Conditions
Japanese Healthy Male Adult Volunteers
Trial Timeline
Nov 1, 2010 → Mar 1, 2011
NCT ID
NCT01253434About E2022 + E2022 + E2022 + E2022 + E2022
E2022 + E2022 + E2022 + E2022 + E2022 is a phase 1 stage product being developed by Eisai for Japanese Healthy Male Adult Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT01253434. Target conditions include Japanese Healthy Male Adult Volunteers.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01253434 | Phase 1 | Completed |
Competing Products
20 competing products in Japanese Healthy Male Adult Volunteers